PHM from Pittsburgh

Title: Opioid Use Disorders in Pediatrics

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. Review definition and epidemiology of Opioid Use Disorders (OUD).

   2. Review mechanism of action of Opioids.

   3. Review medications for treatment of Opioid Use Disorders (OUD) and harm reduction principles.

   4. Review considerations for when and adolescent is admitted to the hospital who happens to have OUD.

Faculty:

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Maggie Shang, MD — Clinical Instructor, Department of Internal Medicine at the University of Pittsburgh School of Medicine.

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 12/1/2023, Expires 12/1/2026

The direct link to the course is provided below:

Pediatric Hospital Medicine: Opioid Use Disorders in Pediatrics - PHM Podcast series

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24793&dev=true

Title: New RSV Monoclonal Antibody and Vaccine Conversation

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. Review how monoclonal antibodies work in fightin disease.
2. Review Nirsevimab and the ACIP and AAP reccomendations for its use.
3. Discuss how monoclonal antibodies are different from vaccines and discuss the new RSV vaccines being released.

Faculty:

Planning Committee:

Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

John Williams, MD — Professor in the Dept. of Pediatrics at the University of Pittsburgh, Division Director for Pediatric Infectious Disease Division at University of Pittsburgh Medical Center (UPMC).

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 8/29/2023, Expires 8/29/2026

The direct link to the course is provided below:

COMING SOON!!

This is part of our annual series at the Pediatric Hospital Medicine National Conference where we ask some of the conference attendees to join us to discuss which sessions of the conference they went to and learned. Today we are lucky enough to be joined by Drs. Kishore Vellody, Kathryn Connor, Lingie Chiu, Anna Ogena and Martiza Harper. This episode is not associated with CME, we apologize for any inconvienence associated with that.

Title: Breastfeeding Part 2

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. Review the physiology of breastfeeding, expected weight gain in an exclusively breastfed infant and how breastmilk changes as an infant ages.
2. Review breastfeeding in an infant with bronchiolitis who may be tachypneic and the risk of aspiration.
3. Review changes in breastfeeding recommendations from the AAP and WHO.

Faculty:

Planning Committee:

Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Carly Dulabon, MD — Assistant Professor of Pediatrics at Northeast Ohio Medical University, Akron Children's Hospital

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 7/3/2023, Expires 7/3/2026

The direct link to the course is provided below:

COMING SOON!!

Activity Title: Pediatric Hospital Medicine: Corticosteroids in Bronchiolitis? A Conversation with an Intensivist

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

Faculty:

Planning Committee:

Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Jonathan Pelletier, MD — Assistant Professor of Pediatrics at Northeast Ohio Medical University, Akron Children's Hospital

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 06/05/2023, Expires 06/05/2026

The direct link to the course (EM_113176) is provided below:

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24414&dev=true

Course: Albuterol for Bronchiolitis? - A Conversation with an Intenstivist

Course Director: Tony R Tarchichi MD - Associate Professor in Dept of Pediatrics at the University of Pittsburgh School of Medicine

Course Director: Jonathan Pelletier MD - Associate Professor of Pediatrics at the Northeast Ohio Medical University

This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.

This episode is Albuterol for Bronchiolitis? - A Conversation with an Intenstivist. As always there is free CME credit of up to 1 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.

______________________________________________________

Objectives: Upon completion of this activity, participants will be able to:

1. Discuss the increase in albuterol usage for bronchiolitis occurring in pediatric intensive care units nationally.

2. Discuss the evidence base behind using albuterol for bronchiolitis in critically ill pediatric patients.

3. Discuss how the American Academy of Pediatrics bronchiolitis guidelines apply to the patients in the pediatric intensive care units.

Released: 3/13/2023, Reviewed 3/13/2023, Expire: 3/13/2024

If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account:

Step 1. Create an Account

https://www.hsconnect.pitt.edu/HSC/home/create-account.do

If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training:

Step 2. To access the test for CME credit:

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24253&dev=true

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

This episode was made in partnership with the Newborn Medicine subcommitee of the American Academy of Pediatrics - Section on Hospital Medicine.

Course: Hyperbilirubinemia in the newborn 35 weeks or more – Updated Guidelines!

Course Director: Tony R Tarchichi MD - Associate Professor in Dept of Pediatrics at the University of Pittsburgh School of Medicine

Course Director: Alison Volpe Holmes, MD, MS, MPH. - Associate Professor of Pediatrics and of the Dartmouth Institute, Geisel School of Medicine at Dartmouth

This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.

This episode is Hyperbilirubinemia in the newborn 35 weeks or more – Updated Guidelines! As always there is free CME credit of up to 1.25 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.

______________________________________________________

Objectives: Upon completion of this activity, participants will be able to:

1. Review the treatment of hyperbilirubinemia in the newborn 35 weeks or more.
2. Review the definition of Kernicterus.
3. Review the management and when to escalate care in infants more than 35 weeks old who have hyperbilirubinemia.

Released: 12/18/2022, Reviewed 12/18/2022, Expire: 12/18/2023

If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account:

Step 1. Create an Account

https://www.hsconnect.pitt.edu/HSC/home/create-account.do

If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training:

Step 2. To access the test for CME credit:

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=23974&dev=true

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of (1.25) AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course: Discussing the SCOUT-CAP Trial

Course Director: Tony R Tarchichi MD - Associate Professor in Dept of Pediatrics at the University of Pittsburgh School of Medicine

Course Director: Derek Williams M.D. - Associate Professor in Dept of Pediatrics at Vanderbilt University School of Medicine

This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.

This episode is Discussing the SCOUT-CAP Trial. As always there is free CME credit of up to 1 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.

______________________________________________________

Objectives: Upon completion of this activity, participants will be able to:

1. Discuss the methodology used for the SCOUT-CAP Trial.
2. Discuss the results and their transmissibility to inpatient pediatrics.
3. Discuss the background information for the trial and the benefits of safely treating community acquired pneumonia for less time.

Released: 11/17/2022, Reviewed 11/17/2022, Expire: 11/17/2023

If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account:

Step 1. Create an Account

https://www.hsconnect.pitt.edu/HSC/home/create-account.do

If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training:

Step 2. To access the test for CME credit:

Coming Soon!!!

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of (1) AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course: Enterovirus D68 and Acute Flaccid Myelitis in 2022

Course Director: Tony R Tarchichi MD - Associate Professor in Dept of Pediatrics at the University of Pittsburgh School of Medicine

Course Director: Megan Culler Freeman MD, PhD - Clinical Instructor in the Dept of Pediatrics at the University of Pittsburgh School of Medicine

This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.

This episode is Enterovirus D68 and Acute Flaccid Myelitis in 2022. As always there is free CME credit of up to 0.5 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.

______________________________________________________

Objectives: Upon completion of this activity, participants will be able to:

1. Review the epidemiology and virology of Enterovirus D68.
2. Review the presentation, diagnosis and potential treatment of Acute Flaccid Myelitis.
3. Review the link between Enterovirus D68 and Acute Flaccid Myelitis.

Released: 9/19/2022, Reviewed 9/19/2022, Expire: 9/19/2023

If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account:

Step 1. Create an Account

https://www.hsconnect.pitt.edu/HSC/home/create-account.do

If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training:

Step 2. To access the test for CME credit:

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=23754&dev=true

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of (0.5) AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This is our last episode from the PHM 2022 National Conference in Orlando, Florida. For this episode we are recapping and summarizing one of the most attended lectures at the conference, "Procalcitonin: What is it Good For?" We were fortunate enough to be joined by all three presenters of this talk, Drs. Brittany Slagle, Rebecca Cantu and Sara Sanders from Arkansas Children's Hospital and the University of Arkansas. This episode does not have CME associated with it.

We hope you enjoyed these sessions from the PHM National Conference!